Quoin Pharmaceuticals
QNRX
5 hedge funds and large institutions have $674K invested in Quoin Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, 1 reducing their positions, and 0 closing their positions.
400% more funds holding
Funds holding: 1 → 5 (+4)
97% more capital invested
Capital invested by funds: $342K → $674K (+$332K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$69.8K |
| 2 |
HF
HRT Financial
New York
|
+$69.8K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$69.8K |
| 4 |
VF
Virtu Financial
New York
|
+$69.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$69.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $418K | -$69.8K | -1 | -14% |
|
|
HF
2
HRT Financial
New York
| $65K | +$69.8K | +1 | New |
|
|
VF
3
Virtu Financial
New York
| $64K | +$69.8K | +1 | New |
|
|
4
Citadel Advisors
Miami,
Florida
| $52K | +$69.8K | +1 | New |
|
|
TSS
5
Two Sigma Securities
New York
| $39K | +$69.8K | +1 | New |
|
6
Morgan Stanley
New York
| $16K | – | – | – |
|
|
SPIA
7
Steward Partners Investment Advisory
New York
| $6.28K | – | – | – |
|
8
UBS Group
Zurich,
Switzerland
| $6K | – | – | – |
|
|
VFA
9
Valeo Financial Advisors
Carmel,
Indiana
| $5K | – | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $3K | – | – | – |
|
QNRX Hedge Fund Activity: Q1 2021 in Review
5 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q1 2021, worth a combined $674K — up 97% from $342K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new QNRX positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $69.8K. The largest seller was Renaissance Technologies, cutting an estimated $69.8K.
- 5 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q1 2021, up from 1 in Q4 2020.
- Funds reported $674K of Quoin Pharmaceuticals stock for Q1 2021, up 97% quarter-over-quarter.
- 4 funds opened new Quoin Pharmaceuticals positions in Q1 2021 and 0 closed out, a net change of +4 holders.
- The largest Quoin Pharmaceuticals buyer in Q1 2021 was Citadel Advisors, an estimated $69.8K added.
- The largest Quoin Pharmaceuticals seller in Q1 2021 was Renaissance Technologies, an estimated $69.8K sold.
Based on aggregated 13F filings for Q1 2021.